Uncategorized

The Midwestern health systems were in merger discussions since October 2022.

Truist analysts wrote that Medtronic, Boston Scientific and Edwards Lifesciences could benefit from rising cardiology volumes, while Intuitive Surgical may benefit from improved capital spending.

The payer is taking issue with how regulators calculated quality scores for 2024, after seeing a stars decline that could cause its bonus revenue to fall by $500 million.

The acquisition provides a high-growth addition to Boston Scientific’s urology business, analysts said.

Competitor Medtronic also received a CE mark for a new CGM sensor that can integrate with its 780G pump.

Stacy Sanders will work with regulators to tackle industry consolidation in an effort to rein in rising healthcare costs.

The Inflation Reduction Act, “march-in rights” to take back patents and M&A were among the issues discussed at a Sunday panel in San Francisco ahead of Monday’s start of the J.P. Morgan conference.

Provider groups argued for changes in financial penalties and more information on an appeals process. 

Harpoon has several antibodies in its pipeline that are engineered to redirect a patient’s T cells to recognize and kill cancer cells.

A day after inking an AI deal with Alphabet’s Isomorphic Labs, Novartis is back at it, acquiring Calypso Biotech and tying up with Shanghai Argo in two RNA-i-focused pacts.